T2	intervention 74 88	blue dye alone
T1	control 94 122	triple modality localization
T3	location 419 430	New Zealand
T4	total-participants 655 658	104
T5	eligibility 659 821	patients who had a palpable breast lump that was confirmed to be malignant by radiology and cytology and a clinical diagnosis of stage I or stage II breast cancer
T6	intervention-participants 1037 1039	63
T7	control-participants 1069 1071	41
T8	outcome 1177 1190	sentinel node
T9	iv-bin-abs 1209 1211	57
T10	iv-bin-percent 1213 1216	90%
T11	cv-bin-abs 1247 1249	40
T12	cv-bin-percent 1251 1254	98%
T13	outcome 1349 1387	axillary nodes positive for malignancy
T14	iv-bin-abs 1291 1293	23
T15	iv-bin-percent 1295 1298	37%
T16	cv-bin-abs 1320 1322	23
T17	cv-bin-percent 1324 1327	56%
T18	iv-bin-abs 1399 1402	one
T19	outcome 1403 1421	false negative SNB
T20	cv-bin-abs 1442 1445	two
T21	outcome 1517 1525	accuracy
T22	iv-bin-percent 1529 1532	98%
T23	outcome 1539 1550	sensitivity
T24	cv-bin-percent 1554 1557	96%
T25	outcome 1573 1581	accuracy
T26	cv-bin-percent 1585 1588	95%
T27	outcome 1595 1606	sensitivity
T28	cv-bin-percent 1610 1613	91%
